Pharma Journalist -

Swiss healthcare giant Roche has signed a definitive merger agreement to acquire U.S.-based artificial intelligence pathology company PathAI, strengthening its position in the rapidly…
Read More...

Altasciences and Certara have announced a strategic partnership aimed at accelerating early-stage drug development by integrating advanced modeling and simulation technologies into…
Read More...

Italian drugmaker Angelini Pharma has agreed to acquire U.S.-based rare disease specialist Catalyst Pharmaceuticals in a cash transaction valued at approximately $4.1 billion, marking…
Read More...

Novartis has begun construction on a new radioligand therapy (RLT) manufacturing facility in Denton, Texas, as part of the company’s expanding multibillion-dollar investment in U.S.…
Read More...

Eli Lilly and Company has announced an additional $4.5 billion investment in its Lebanon, Indiana manufacturing operations, strengthening the pharmaceutical giant’s long-term commitment…
Read More...

Artera has received U.S. Food and Drug Administration clearance for its ArteraAI Breast test, marking a significant milestone in the use of artificial intelligence for cancer…
Read More...

Halozyme Therapeutics and Oruka Therapeutics have entered into a global exclusive collaboration and licensing agreement focused on advancing innovative drug delivery technology for…
Read More...

Waiv, formerly known as Owkin Dx, has entered into a collaboration with Daiichi Sankyo to support digital pathology biomarker discovery for an antibody-drug conjugate (ADC) development…
Read More...

MSD has announced the successful completion of its acquisition of Terns Pharmaceuticals, Inc., marking a significant move to strengthen its oncology pipeline and expand its portfolio of…
Read More...

Madrigal Pharmaceuticals, Inc. has entered into an exclusive global licensing agreement with Arrowhead Pharmaceuticals to develop and commercialize ARO-PNPLA3, a clinical-stage…
Read More...